Previous studies reported that, in breast cancer cells, PRSS23 was co-expressed with estrogen receptor α (ERα), and PRSS23 knockdown may suppress estrogen-driven cell proliferation of breast cancer cells [26]. Here, ESR1 is linked to breast carcinoma.